Executive Vice President of $COHR sells 47,751 shares in insider sale

According to recent disclosures, Giovanni Barbarossa, the Executive Vice President of COHR, divested 47,751 shares of the company on October 29, 2025, amounting to an estimated $6,707,191. This transaction represented a sale of about 16.9% of Barbarossa’s holdings in this particular class of stock, reducing their ownership to 235,593 shares in total.

Looking at the broader picture of insider trading activity within COHR, a total of 25 transactions have taken place on the open market in the last six months involving company insiders. Notably, all the transactions were divestitures, with no recent purchases noted. Giovanni Barbarossa stands out for having sold 59,480 shares, totaling approximately $8,362,173. Other significant sales include Shaker Sadasivam selling 29,292 shares, Christopher Koeppen offloading 19,838 shares, Stephen A Skaggs divesting 6,000 shares, Julie Sheridan Eng selling 7,136 shares, Howard H. Xia disposing of 6,000 shares, and Lisa Neal-Graves parting with 1,200 shares.

Shifting focus to hedge fund activity surrounding COHR, a multitude of institutional investors have made moves in their portfolios concerning the company’s stock. Notably, 373 institutional investors saw fit to add shares of COHR, while 273 others decreased their holdings in the most recent quarter. High-profile changes include Dodge & Cox removing 4,706,174 shares from their portfolio, BlackRock, Inc. divesting 2,532,860 shares, and Invesco Ltd. reducing their holdings by 2,056,449 shares. Conversely, Ameriprise Financial Inc. bolstered their position by adding 1,389,126 shares, and Citadel Advisors LLC followed suit by acquiring 1,279,310 shares.

Moreover, members of Congress have engaged in trading activity related to COHR stock, with one purchase recorded in the past six months. Representative Lisa C. McClain made a purchase of up to $15,000 worth of shares on June 17. When it comes to analyst sentiment towards COHR, 10 firms have issued buy ratings for the stock, with no sell ratings expressed. Noteworthy recent ratings include “Positive” from Susquehanna, “Overweight” from Barclays, and “Buy” from Needham and Stifel. Various price targets have also been set for COHR, with a median target of $120. Notable targets include $150 by Mehdi Hosseini, $135 by Tom O’Malley, and $105 by Vivek Arya.

It is vital to emphasize that this article does not provide financial advice, and readers are encouraged to refer to the disclaimers provided by Quiver Quantitative for additional information.